Alphatec Holdings Inc. | Small-cap | Healthcare
$10.93
-0.55%
| Alphatec Holdings Stock Comparison:
Alphatec Holdings vs Abbott LaboratoriesAlphatec Holdings vs Boston ScientificAlphatec Holdings vs UFP TechnologiesAlphatec Holdings vs NovocureAlphatec Holdings vs EnovisAlphatec Holdings vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 611.6M
Gross Profit 424.3M 69.37%
Operating Income -122.9M -20.10%
Net Income -162.1M -26.51%
EPS (Diluted) -$1.13

Balance Sheet Metrics

Total Assets 775.7M
Total Liabilities 789.9M
Shareholders Equity -14.2M

Cash Flow Metrics

Operating Cash Flow -61.3M
Free Cash Flow -137.8M

Revenue & Profitability Trend

Alphatec Holdings Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue611.6M482.3M350.9M243.2M144.9M
Cost of Goods Sold187.3M172.1M117.8M85.4M42.4M
Gross Profit424.3M310.2M233.1M157.8M102.5M
Operating Expenses530.9M444.2M344.0M261.3M147.9M
Operating Income-122.9M-148.3M-121.1M-108.9M-46.1M
Pre-tax Income-162.1M-186.9M-152.0M-144.2M-78.8M
Income Tax50.0K-277.0K-716.0K-1.1M145.0K
Net Income-162.1M-186.6M-151.3M-143.0M-79.0M
EPS (Diluted)-$1.13-$1.54-$1.47-$1.50-$1.18

Income Statement Trend

Alphatec Holdings Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets417.4M451.1M255.6M331.2M184.2M
Non-Current Assets358.3M354.1M265.3M240.9M77.1M
Total Assets775.7M805.2M521.0M572.1M261.2M
Liabilities
Current Liabilities153.0M157.6M138.9M101.1M58.3M
Non-Current Liabilities636.9M569.5M416.8M391.5M73.0M
Total Liabilities789.9M727.1M555.6M492.6M131.3M
Equity
Total Shareholders Equity-14.2M78.1M-34.7M79.4M129.9M

Balance Sheet Composition

Alphatec Holdings Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-162.1M-186.6M-151.3M-143.0M-79.0M
Operating Cash Flow-61.3M-101.7M-101.6M-106.2M-67.5M
Investing Activities
Capital Expenditures-83.2M-80.5M-49.5M-68.5M-23.1M
Investing Cash Flow-83.2M-135.5M-49.5M-157.8M-23.1M
Financing Activities
Dividends Paid-----
Financing Cash Flow56.8M356.9M31.2M312.0M130.8M
Free Cash Flow-137.8M-165.5M-133.4M-141.9M-70.3M

Cash Flow Trend

Alphatec Holdings Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -9.63
Forward P/E -16.71
Price to Book -18.58
Price to Sales 2.47
PEG Ratio -16.71

Profitability Ratios

Profit Margin -25.77%
Operating Margin -18.74%
Return on Equity 1,144.21%
Return on Assets -9.33%

Financial Health

Current Ratio 2.76
Debt to Equity -6.76
Beta 1.11

Per Share Data

EPS (TTM) -$1.14
Book Value per Share -$0.59
Revenue per Share $4.45

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
atec1.6B-9.63-18.581,144.21%-25.77%-6.76
Abbott Laboratories 231.9B17.314.7530.65%31.89%27.09
Boston Scientific 149.9B73.946.759.50%11.58%52.16
UFP Technologies 1.9B29.895.2019.36%11.59%55.05
Novocure 1.9B-10.905.12-45.52%-26.41%192.49
Enovis 1.7B-2.010.66-27.35%-37.65%55.68

Financial data is updated regularly. All figures are in the company's reporting currency.